Fewer patients in the deferred stenting group had no - / slow-reflow ( 14 [ 29 % ] vs. 3 [ 6 % ] ; p = 0.006 ) , no reflow ( 7 [ 14 % ] vs. 1 [ 2 % ] ; p = 0.052 ) and intraprocedural thrombotic events ( 16 [ 33 % ] vs. 5 [ 10 % ] ; p = 0.010 ) .